0001171843-18-004579.txt : 20180611 0001171843-18-004579.hdr.sgml : 20180611 20180611163149 ACCESSION NUMBER: 0001171843-18-004579 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180608 FILED AS OF DATE: 20180611 DATE AS OF CHANGE: 20180611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Canute Scott A CENTRAL INDEX KEY: 0001303416 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 18892350 MAIL ADDRESS: STREET 1: FLEXION THERAPEUTICS, INC. STREET 2: 10 MALL ROAD, SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 formfour.xml FORM 4 X0306 4 2018-06-08 0 0001359931 PROTEON THERAPEUTICS INC PRTO 0001303416 Canute Scott A C/O PROTEON THERAPEUTICS, INC. 200 WEST STREET WALTHAM MA 02451 1 0 0 0 Stock Option (Right to Buy) 2.50 2018-06-08 4 A 0 12700 0 A 2028-06-07 Common Stock 12700 12700 D The options were granted on June 8, 2018 and the shares underlying this option will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders. /s/ George A. Eldridge, attorney-in fact for Scott Canute 2018-06-11